InSysBio to present its ePoster at ECTRIMS 2022

events
Conference
October 25, 2022

October 25, 2022

InSysBio team is going to present its poster in frames of the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2022) which is to be held October 26-28, Amsterdam, the Netherlands. The ePoster is going to be presented in frames of "Pathology and pathogenesis of MS - Neurodegeneration" ePoster Area, October 26, 08:00 - 08:00 CEST:

  • EP0960 (10) - "Neurodegeneration quantitative systems pharmacology modelling for analysis of multiple sclerosis therapy" by Polina Pchelintseva1, Anna Mishina1, Tatiana Karelina2

Affiliation: (1) InSysBio, Moscow, Russia; (2) InSysBio CY, Paphos, Cyprus

 

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Edinburgh, UK (INSYSBIO UK LIMITED), Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

November 2022
MoTuWeThFrSaSu
 
1
2
3
4
5
6
7
8
9
1. 09 Nov 2022 13:21 InSysBio to start the operation of new Headquarters and new branch office InSysBio announces the start of operation of Headquarters in the United Kingdom. At the same time, the new branch office has been founded in Cyprus and part of InSysBio team has relocated there, thus, expanding the company’s presence.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
    
Upcoming Events
Tags
Latest News
09.11
InSysBio to start the operation of new Headquarters and new branch office
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0